CHENGZHI(SZ:000990) Ge Long Hui A P P·2026-01-29 07:44Core Viewpoint - The company is expanding its product sales network globally, particularly in Europe, America, and Asia, with a focus on its new product series and NAD+ products [1] Group 1: Product Development and Sales - The new product series from the subsidiary RIAGEV is set to cover major global markets including Europe, America, and Asia [1] - Sales of related products are expected to increase steadily in Europe, America, and Asia by 2025 [1] Group 2: Strategic Focus - The company will continue to enhance its investment in synthetic biology applications within the life sciences sector [1] - There is an ongoing effort to extend the industrial chain, enrich the product structure, and enhance brand value [1] - The goal is to build a more competitive synthetic biology business segment [1]